ReGen Biologics’ Collagen Scaffold Goes To FDA Panel Nov. 14
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopaedic and Rehabilitation Devices Panel will meet Nov. 14 to review an updated 510(k) submission for ReGen Biologics' Collagen Scaffold knee cartilage repair product